![Valeria Povolotsky](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Valeria Povolotsky
Profile
Valeria Povolotsky worked as a Director at Felicitex Therapeutics, Inc.
Former positions of Valeria Povolotsky
Companies | Position | End |
---|---|---|
Felicitex Therapeutics, Inc.
![]() Felicitex Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Felicitex Therapeutics, Inc. is a pre-clinical stage oncology drug development company developing therapies against cancer and diabetes. It operates through the Felicitex Business and TraMeta segments. The Felicitex Business segment handles the design and patents of small molecules and related methods to selectively disrupt dormant cancer cells in a manner that is specific to the disease and tissue context. The TarMeta segment built a drug discovery platform for small molecule inhibitors targeting cancer. The company was founded by Maria Vilenchik and Michael Frid on May 4, 2012 and is headquartered in Natick, MA. | Director/Board Member | 01/02/2022 |
Experiences
Positions held
Linked companies
Private companies | 1 |
---|---|
Felicitex Therapeutics, Inc.
![]() Felicitex Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Felicitex Therapeutics, Inc. is a pre-clinical stage oncology drug development company developing therapies against cancer and diabetes. It operates through the Felicitex Business and TraMeta segments. The Felicitex Business segment handles the design and patents of small molecules and related methods to selectively disrupt dormant cancer cells in a manner that is specific to the disease and tissue context. The TarMeta segment built a drug discovery platform for small molecule inhibitors targeting cancer. The company was founded by Maria Vilenchik and Michael Frid on May 4, 2012 and is headquartered in Natick, MA. | Commercial Services |
- Stock Market
- Insiders
- Valeria Povolotsky